FGAM
VNDA icon

Financial Gravity Asset Management’s Vanda Pharmaceuticals VNDA Stock Holding History

Financial Gravity Asset Management’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-185
Closed -$17K – 1006
2021
Q3 		$17K Buy
185
+10
+6% +$175 0.01% 827
2021
Q2 		$22K Buy
175
+7
+4% +$125 0.01% 790
2021
Q1 		$2.52K Buy
+168
New +$2.72K 0.05% 222

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EIP
Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Financial Gravity Asset Management's VNDA Position: Q4 2021 in Review

Financial Gravity Asset Management sold out of Vanda Pharmaceuticals (VNDA) in Q4 2021, closing a stake of 185 shares — an estimated $17K sold.

Financial Gravity Asset Management first reported a position in VNDA in Q1 2021 and held it in 3 quarters. The position peaked at $22K in Q2 2021. 198 funds tracked by Wall St. Rank hold VNDA as of Q4 2021.

  • Financial Gravity Asset Management reported no remaining Vanda Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
  • Financial Gravity Asset Management sold 185 Vanda Pharmaceuticals shares in Q4 2021, an estimated $17K.
  • Financial Gravity Asset Management first reported a position in Vanda Pharmaceuticals in Q1 2021 and held it in 3 quarters.
  • Financial Gravity Asset Management's Vanda Pharmaceuticals position peaked at $22K in Q2 2021.
  • 198 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2021.

Based on Financial Gravity Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.